Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia (NCT04094090)

🧪 Interventions in This Study

• PXL-330 Platinum device for crosslinking with Peschke riboflavin solution (COMBINATION_PRODUCT)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Goodman Eye Center — San Francisco, California

📞 Contact the Study Coordinator

Phone: (415) 474-3333

Email: swong@goodmaneyecenter.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Keratoconus

• Initial Correction Keratoconus — Chicago, Illinois
• McNeel Eye Center Corneal Crosslinking Study — Boise, Idaho
• Assessing Patient Engagement in Keratoconus Clinical Research — San Francisco, California
• Outcomes of CTAK Surgery — Palo Alto, California
• A Randomized Clinical Trial of Ex Vivo Corneal Cross-Linking of Donor Keratoplasty Tissue for Keratoconus Used for Keratoplasty in Keratoconus Patients — Boston, Massachusetts
• OCT in Diagnosis of Irregular Corneas — Portland, Oregon

Explore by condition: All Keratoconus clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.